[1]
“A study of virologic and immunologic efficacy of a fixed dose combination of TDF 300 mg /emtricitabine ”, AJAHR, vol. 6, no. 1, pp. 8–10, Aug. 2018, Accessed: Oct. 28, 2026. [Online]. Available: https://kevinpage.org/index.php/AJAHR/article/view/401